The decision made with regard to these NICE 30 day TAs can now be found at: https://ntag.nhs.uk/meetings/decision-summaries/
- NICE TA 1075: Dapagliflozin for treating chronic kidney disease
- NICE TA 1080: Mirikizumab for previously treated moderately to severely active Crohn’s disease
- NICE TA 1085: Vanzacaftor-tezacaftor-deutivacaftor for treating cystic fibrosis with 1 or more F508del mutations in the CFTR gene in people 6 years and over